Browse Category

NASDAQ:ASTS News 24 January 2026 - 7 February 2026

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
AST SpaceMobile stock sinks nearly 10% as AT&T’s Amazon satellite move spooks traders

AST SpaceMobile stock sinks nearly 10% as AT&T’s Amazon satellite move spooks traders

AST SpaceMobile shares fell 9.9% to $93.27 Thursday after AT&T announced a new satellite broadband deal with Amazon, fueling investor concerns about competition. Trading volume reached 15.8 million shares. The drop followed a 10.6% decline Wednesday. AT&T said its Amazon partnership targets fixed business broadband, not mobile, and does not affect its plans with AST.
AST SpaceMobile (ASTS) stock sinks as AT&T taps Amazon Leo for satellite connectivity

AST SpaceMobile (ASTS) stock sinks as AT&T taps Amazon Leo for satellite connectivity

Shares of AST SpaceMobile dropped 7.8% to $95.45 by midday Thursday amid volatility in space-sector stocks. AT&T and Amazon Leo announced expanded collaboration on satellite and cloud services, drawing investor focus to U.S. telecom partnerships. Amazon Leo requested a 24-month FCC extension for its satellite network rollout. Pomerantz LLP is investigating claims for AST investors following a recent downgrade.
AST SpaceMobile stock slides 11% after AT&T’s Amazon Leo deal shakes satellite-to-phone trade

AST SpaceMobile stock slides 11% after AT&T’s Amazon Leo deal shakes satellite-to-phone trade

AST SpaceMobile shares fell 10.6% to $103.50 after AT&T announced new agreements with Amazon’s Leo satellite project and AWS. AT&T said the Amazon deal targets fixed broadband for businesses and does not affect its partnership with AST. Investors are watching for updates at Mobile World Congress and the timing of AST’s next satellite launch. Globalstar and Iridium also declined, while AT&T gained 1.5%.
5 February 2026
AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile shares fell 10% to $103.73 after AT&T announced a new satellite broadband partnership with AWS and Amazon Leo, focused on business customers. Trading volume topped 15.9 million shares. The drop followed investor concerns over AT&T’s commitment to AST’s direct-to-phone satellite plans. AST’s next satellite launch is scheduled for late February.
4 February 2026
AST SpaceMobile (ASTS) stock jumps 6% as SpaceX-xAI merger lifts U.S. space shares

AST SpaceMobile (ASTS) stock jumps 6% as SpaceX-xAI merger lifts U.S. space shares

AST SpaceMobile shares rose 6.3% to $111.11 Tuesday after a sector rally triggered by SpaceX’s planned merger with xAI. About 11.5 million shares traded as investors focused on AST’s upcoming BlueBird 7 satellite launch and a new U.S. Missile Defense Agency contract. Scotiabank recently downgraded the stock, citing valuation concerns and lack of retail customers.
SpaceX buys Musk’s xAI in record $1.25 trillion deal as space stocks jump premarket

SpaceX buys Musk’s xAI in record $1.25 trillion deal as space stocks jump premarket

SpaceX acquired xAI, valuing the combined company at $1.25 trillion, according to sources. U.S.-listed space stocks rose in premarket trading after the news. xAI investors will receive 0.1433 SpaceX shares per xAI share, with some executives able to cash out at $75.46 per share. Attention has shifted to the timing of SpaceX’s IPO, which could come as soon as June.
AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile shares fell 8.7% to $111.50 Friday, swinging from a session high of $129.74 to a low of $109.04 on heavy volume. Vanguard disclosed a 7.68% stake in the company as of Dec. 31 in a regulatory filing. Investors are watching for the planned late-February BlueBird 7 satellite launch aboard Blue Origin’s New Glenn-3 rocket.
AST SpaceMobile stock price jumps 9% as traders refocus on BlueBird 7 launch timeline

AST SpaceMobile stock price jumps 9% as traders refocus on BlueBird 7 launch timeline

AST SpaceMobile shares surged 9% to $121.42 Wednesday afternoon on heavy volume, as investors eyed the late-February BlueBird 7 satellite launch and a 2026 commercial rollout. The company aims to deploy 45–60 satellites by year-end but faces skepticism over whether it can maintain the planned launch pace. Analyst Tim Farrar called the targets unrealistic if launches slow. Competition from SpaceX’s Starlink is intensifying.
ASTS stock price rises as AST SpaceMobile’s 2026 launch pace comes back under the microscope

ASTS stock price rises as AST SpaceMobile’s 2026 launch pace comes back under the microscope

AST SpaceMobile shares rose 4.6% to $109.63 Tuesday afternoon as investors await the BlueBird 7 satellite launch, now set for late February on Blue Origin’s New Glenn rocket. Industry analysts doubt the company can meet its 2026 target of 45–60 satellites, citing slow launch progress. Pomerantz LLP launched an investor investigation. COO Shanti Gupta amended a filing to correct a 50,000-share overstatement.
27 January 2026
Space and defense stocks face earnings week after Karman outlook bump, AST launch plan

Space and defense stocks face earnings week after Karman outlook bump, AST launch plan

The iShares U.S. Aerospace & Defense ETF fell 0.3% to $235.07 Friday as sector stocks closed mixed ahead of major earnings. Karman Holdings dropped 3% after raising its outlook and announcing a $220 million acquisition. AST SpaceMobile slipped 2.4% after setting a late-February satellite launch. L3Harris edged down 0.3% but raised its dividend to $1.25 per share.
AST SpaceMobile stock price slips after hours as BlueBird 7 launch timeline comes into focus

AST SpaceMobile stock price slips after hours as BlueBird 7 launch timeline comes into focus

AST SpaceMobile shares fell 2.4% to $113.57 Friday and slipped another 0.3% after hours as investors tracked the company’s satellite launch schedule. AST plans to launch its BlueBird 7 satellite on Blue Origin’s New Glenn-3 in late February from Cape Canaveral. The company targets one launch every one to two months through 2026. Traders remain focused on whether AST can keep up the planned pace.
1 2 3 7

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop